Article
A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Feb 2025
Valentine Mark C, Wong Amanda, Chen Ling, Du Feiyu, Hughes Andrew E O, Spencer David H, Duncavage Eric J, Sun Lulu
Abstract excerpt
OBJECTIVE: The molecular classification of endometrial cancer into POLE-ultra-mutated, mismatch repair-deficient, p53-mutated, and no specific molecular profile sub-types has significant prognostic value and is recommended in the evaluation of all patients with endometrial cancer. Nonetheless, there has been inconsistent clinical implementation. One possible barrier is the current practice of using several...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
